These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32613637)

  • 1. Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19.
    Tutunchi H; Naeini F; Ostadrahimi A; Hosseinzadeh-Attar MJ
    Phytother Res; 2020 Dec; 34(12):3137-3147. PubMed ID: 32613637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective: The Potential Effects of Naringenin in COVID-19.
    Alberca RW; Teixeira FME; Beserra DR; de Oliveira EA; Andrade MMS; Pietrobon AJ; Sato MN
    Front Immunol; 2020; 11():570919. PubMed ID: 33101291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data.
    Rommasi F; Nasiri MJ; Mirsaiedi M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4163-4173. PubMed ID: 34156698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
    Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
    Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Antiviral Activity of Licorice Help Fight COVID-19 Infection?
    Diomede L; Beeg M; Gamba A; Fumagalli O; Gobbi M; Salmona M
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34201172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL
    Mouffouk C; Mouffouk S; Mouffouk S; Hambaba L; Haba H
    Eur J Pharmacol; 2021 Jan; 891():173759. PubMed ID: 33249077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.
    Bai X; Hippensteel J; Leavitt A; Maloney JP; Beckham D; Garcia C; Li Q; Freed BM; Ordway D; Sandhaus RA; Chan ED
    Med Hypotheses; 2021 Jan; 146():110394. PubMed ID: 33239231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Discovery of Naringenin as Endolysosomal Two-Pore Channel Inhibitor and Its Emerging Role in SARS-CoV-2 Infection.
    D'Amore A; Gradogna A; Palombi F; Minicozzi V; Ceccarelli M; Carpaneto A; Filippini A
    Cells; 2021 May; 10(5):. PubMed ID: 34067054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment.
    Kate Gadanec L; Qaradakhi T; Renee McSweeney K; Ashiana Ali B; Zulli A; Apostolopoulos V
    Future Microbiol; 2021 Mar; 16():205-209. PubMed ID: 33569984
    [No Abstract]   [Full Text] [Related]  

  • 10. Niclosamide for Covid-19: bridging the gap.
    Al-Kuraishy HM; Al-Gareeb AI; Alzahrani KJ; Alexiou A; Batiha GE
    Mol Biol Rep; 2021 Dec; 48(12):8195-8202. PubMed ID: 34664162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Malekmohammad K; Rafieian-Kopaei M
    Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies.
    Ali AM; Kunugi H
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33669054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-Zika virus and anti-tumoral activity of the citrus flavanone lipophilic naringenin-based compounds.
    Albuquerque de Oliveira Mendes L; Ponciano CS; Depieri Cataneo AH; Wowk PF; Bordignon J; Silva H; Vieira de Almeida M; Ávila EP
    Chem Biol Interact; 2020 Nov; 331():109218. PubMed ID: 32916141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.
    Khazeei Tabari MA; Iranpanah A; Bahramsoltani R; Rahimi R
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34202374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.
    Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N
    J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity.
    Hamdy R; Fayed B; Mostafa A; Shama NMA; Mahmoud SH; Mehta CH; Nayak Y; M Soliman SS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies.
    Boozari M; Hosseinzadeh H
    Phytother Res; 2021 Feb; 35(2):864-876. PubMed ID: 32985017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases.
    Li Z; Wu J; Zhou J; Yuan B; Chen J; Wu W; Mo L; Qu Z; Zhou F; Dong Y; Huang K; Liu Z; Wang T; Symmes D; Gu J; Sho E; Zhang J; Chen R; Xu Y
    mBio; 2021 Oct; 12(5):e0254221. PubMed ID: 34634931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.